Skip to main content
TipRanks
Go Ultimate75% OFF

Saniona AB (0RQJ) AI Stock Analysis

0 Followers
GB:0RQJ

Saniona AB

(LSE:0RQJ)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong ProfitabilityThe sharp move from substantial losses to approximately 51% net and 55% EBIT margins demonstrates strong current earnings power. If maintained, this profitability can support internal investment, improve resilience, and provide a stronger foundation for advancing the company’s development pipeline.
Negative Factors
Revenue VolatilityThe latest TTM revenue decline of 110% shows that recent earnings and revenue performance may not be consistently repeatable. Such volatility weakens visibility into future operating results and makes it harder to plan research spending, assess pipeline funding capacity, or judge the durability of current profitability.

Saniona AB (0RQJ) vs. iShares MSCI United Kingdom ETF (EWC)

-50%-25%0%25%50%75%GB:0RQJ-28.13%EWC+19.20%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
SEK 1.63B
Dividend Yield
―
Average Volume (3M)
10.49K
Price to Earnings (P/E)
8.8
Beta (1Y)
0.85
Revenue Growth
24.98%
EPS Growth
-31.44%
Country
UK
Employees
44
Sector
Healthcare
Sector Strength
51
Industry
Biotechnology

Saniona AB Business Overview & Revenue Model

Company Description

Saniona AB (publ), founded in 2011 and based in Glostrup, Denmark, is a biopharmaceutical company focused on rare diseases. It specializes in discovering, developing, and commercializing treatments specifically targeting central nervous system disord...

Saniona AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

GB:0RQJ against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:CAMXSE:CAMX78OutperformSEK 44.18B57.4416.50%―2.96%-4.07%
SE:BIOA.BSE:BIOA.B65NeutralSEK 27.05B256.135.18%0.70%-46.09%-90.13%
SE:HNSASE:HNSA60NeutralSEK 4.90B-6.10――68.88%10.63%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
SE:ALZCURSE:ALZCUR49NeutralSEK 852.21M10.30105.09%―――

* Healthcare Sector Average

Performance Comparison

0%200%400%GB:0RQJSE:HNSASE:MVIRSE:CAMXSE:ALZCURSE:BIOA.BDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:0RQJ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0RQJSaniona AB11.70-5.22-30.85%
SE:HNSAHansa Biopharma48.1820.3673.18%
SE:MVIRMedivir1.120.68155.71%
SE:CAMXCamurus AB729.50115.0018.71%
SE:ALZCURAlzeCure Pharma AB6.184.40247.78%
SE:BIOA.BBioArctic AB Class B304.8022.087.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.